GOC Nexus is arriving at ICBC Berlin this year as it enters full operational launch, following the achievement of EU-GMP approval while advancing key validation processes.
At the event, the company will be presenting the IP protected cold plasma technology for cannabis, currently in validation for decontamination applications, while already authorized for use in pharmaceutical drying. This non-chemical, GMP-compliant approach is designed to support product quality, safety, and regulatory integrity.
"This year marks an important transition for GOC Nexus," the company team explains. "We are moving from validation into full-scale operations, and ICBC Berlin gives us the opportunity to present our technology to the wider European market at exactly the right moment."
© GOC Nexus
For GOC Nexus, ICBC Berlin is a strategic meeting point as the company begins to scale its services across Europe. "It is one of the most important gatherings for the European cannabis industry," the team says. "As we begin operations, it allows us to connect with other business professionals, meet existing partners and friends, and create new synergies throughout the ecosystem."
From the company's perspective, the European cannabis industry is facing a set of challenges that will define its next phase of growth. "Ensuring GMP compliance across processing and supply chains is critical," the team notes. "At the same time, there is a need to create reliable pathways for companies entering the German and broader EU market, while minimizing the risks of contamination and supply disruptions for both producers and patients."
According to GOC Nexus, addressing these issues is central to building a resilient, quality-driven European cannabis sector that can support long-term growth and regulatory confidence.
You can meet the company at booth 200
For more information:
GOC-NEXUS
www.goc-nexus.com
